HEADER MEMBRANE PROTEIN 19-SEP-23 8WFJ TITLE HUMAN GLYCINE TRANSPORTER 1 IN COMPLEX WITH ALX-5407 IN INWARD FACING TITLE 2 CONFORMATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: SODIUM- AND CHLORIDE-DEPENDENT GLYCINE TRANSPORTER 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: GLYT-1,GLYT1,SOLUTE CARRIER FAMILY 6 MEMBER 9; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SLC6A9; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HEK293F KEYWDS GLYT1, ALX-5407, INWARD-OPEN, MEMBRANE PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR Y.WEI,Y.ZHAO REVDAT 4 02-JUL-25 8WFJ 1 REMARK REVDAT 3 13-NOV-24 8WFJ 1 REMARK REVDAT 2 17-APR-24 8WFJ 1 JRNL REVDAT 1 03-APR-24 8WFJ 0 JRNL AUTH Y.WEI,R.LI,Y.MENG,T.HU,J.ZHAO,Y.GAO,Q.BAI,N.LI,Y.ZHAO JRNL TITL TRANSPORT MECHANISM AND PHARMACOLOGY OF THE HUMAN GLYT1. JRNL REF CELL V. 187 1719 2024 JRNL REFN ISSN 1097-4172 JRNL PMID 38513663 JRNL DOI 10.1016/J.CELL.2024.02.026 REMARK 2 REMARK 2 RESOLUTION. 3.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : PHENIX REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.350 REMARK 3 NUMBER OF PARTICLES : 154181 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING ONLY REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8WFJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 20-SEP-23. REMARK 100 THE DEPOSITION ID IS D_1300040886. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : HUMAN GLYCINE TRANSPORTER 1 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K2 SUMMIT (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1200.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2200.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 GLY A 3 REMARK 465 GLY A 4 REMARK 465 ASP A 5 REMARK 465 THR A 6 REMARK 465 ARG A 7 REMARK 465 ALA A 8 REMARK 465 ALA A 9 REMARK 465 ILE A 10 REMARK 465 ALA A 11 REMARK 465 ARG A 12 REMARK 465 PRO A 13 REMARK 465 ARG A 14 REMARK 465 MET A 15 REMARK 465 ALA A 16 REMARK 465 ALA A 17 REMARK 465 ALA A 18 REMARK 465 HIS A 19 REMARK 465 GLY A 20 REMARK 465 PRO A 21 REMARK 465 VAL A 22 REMARK 465 ALA A 23 REMARK 465 PRO A 24 REMARK 465 SER A 25 REMARK 465 SER A 26 REMARK 465 PRO A 27 REMARK 465 GLU A 28 REMARK 465 GLN A 29 REMARK 465 ASN A 30 REMARK 465 GLY A 31 REMARK 465 ALA A 32 REMARK 465 VAL A 33 REMARK 465 PRO A 34 REMARK 465 SER A 35 REMARK 465 GLU A 36 REMARK 465 ALA A 37 REMARK 465 THR A 38 REMARK 465 LYS A 39 REMARK 465 ARG A 40 REMARK 465 ASP A 41 REMARK 465 GLN A 42 REMARK 465 ASN A 43 REMARK 465 LEU A 44 REMARK 465 LYS A 45 REMARK 465 ARG A 46 REMARK 465 GLY A 47 REMARK 465 ASN A 48 REMARK 465 TRP A 49 REMARK 465 GLY A 50 REMARK 465 ASN A 51 REMARK 465 GLN A 52 REMARK 465 ILE A 53 REMARK 465 ALA A 181 REMARK 465 SER A 182 REMARK 465 ASN A 183 REMARK 465 LEU A 184 REMARK 465 THR A 185 REMARK 465 ASN A 186 REMARK 465 GLY A 187 REMARK 465 SER A 188 REMARK 465 ARG A 189 REMARK 465 PRO A 190 REMARK 465 ALA A 191 REMARK 465 ALA A 192 REMARK 465 LEU A 193 REMARK 465 PRO A 194 REMARK 465 SER A 195 REMARK 465 ASN A 196 REMARK 465 LEU A 197 REMARK 465 SER A 198 REMARK 465 HIS A 199 REMARK 465 LEU A 200 REMARK 465 LEU A 201 REMARK 465 ASN A 202 REMARK 465 VAL A 255 REMARK 465 LYS A 256 REMARK 465 SER A 257 REMARK 465 SER A 258 REMARK 465 GLY A 259 REMARK 465 LYS A 260 REMARK 465 VAL A 261 REMARK 465 VAL A 262 REMARK 465 PRO A 602 REMARK 465 ALA A 603 REMARK 465 LEU A 604 REMARK 465 LEU A 605 REMARK 465 GLU A 606 REMARK 465 HIS A 607 REMARK 465 ARG A 608 REMARK 465 THR A 609 REMARK 465 GLY A 610 REMARK 465 ARG A 611 REMARK 465 TYR A 612 REMARK 465 ALA A 613 REMARK 465 PRO A 614 REMARK 465 THR A 615 REMARK 465 ILE A 616 REMARK 465 ALA A 617 REMARK 465 PRO A 618 REMARK 465 SER A 619 REMARK 465 PRO A 620 REMARK 465 GLU A 621 REMARK 465 ASP A 622 REMARK 465 GLY A 623 REMARK 465 PHE A 624 REMARK 465 GLU A 625 REMARK 465 VAL A 626 REMARK 465 GLN A 627 REMARK 465 PRO A 628 REMARK 465 LEU A 629 REMARK 465 HIS A 630 REMARK 465 PRO A 631 REMARK 465 ASP A 632 REMARK 465 LYS A 633 REMARK 465 ALA A 634 REMARK 465 GLN A 635 REMARK 465 ILE A 636 REMARK 465 PRO A 637 REMARK 465 ILE A 638 REMARK 465 VAL A 639 REMARK 465 GLY A 640 REMARK 465 SER A 641 REMARK 465 ASN A 642 REMARK 465 GLY A 643 REMARK 465 SER A 644 REMARK 465 SER A 645 REMARK 465 ARG A 646 REMARK 465 LEU A 647 REMARK 465 GLN A 648 REMARK 465 ASP A 649 REMARK 465 SER A 650 REMARK 465 ARG A 651 REMARK 465 ILE A 652 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 99 CG CD1 CD2 REMARK 470 SER A 243 OG REMARK 470 ILE A 314 CG1 CG2 CD1 REMARK 470 CYS A 579 SG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 118 49.69 -82.38 REMARK 500 SER A 121 87.87 -160.54 REMARK 500 TRP A 163 48.77 -88.28 REMARK 500 ASN A 167 61.59 -69.27 REMARK 500 HIS A 173 49.90 -88.45 REMARK 500 PHE A 264 -4.69 68.40 REMARK 500 TRP A 298 49.68 -88.51 REMARK 500 ILE A 399 64.73 37.24 REMARK 500 GLU A 433 67.08 -101.34 REMARK 500 LYS A 442 54.00 -91.01 REMARK 500 ALA A 478 60.59 -101.22 REMARK 500 ILE A 496 -54.92 -125.06 REMARK 500 VAL A 538 -62.95 -101.95 REMARK 500 TYR A 546 5.18 -69.53 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-37493 RELATED DB: EMDB REMARK 900 HUMAN GLYCINE TRANSPORTER 1 IN COMPLEX WITH ALX-5407 IN INWARD REMARK 900 FACING CONFORMATION DBREF 8WFJ A 1 652 UNP P48067 SC6A9_HUMAN 1 652 SEQRES 1 A 652 MET SER GLY GLY ASP THR ARG ALA ALA ILE ALA ARG PRO SEQRES 2 A 652 ARG MET ALA ALA ALA HIS GLY PRO VAL ALA PRO SER SER SEQRES 3 A 652 PRO GLU GLN ASN GLY ALA VAL PRO SER GLU ALA THR LYS SEQRES 4 A 652 ARG ASP GLN ASN LEU LYS ARG GLY ASN TRP GLY ASN GLN SEQRES 5 A 652 ILE GLU PHE VAL LEU THR SER VAL GLY TYR ALA VAL GLY SEQRES 6 A 652 LEU GLY ASN VAL TRP ARG PHE PRO TYR LEU CYS TYR ARG SEQRES 7 A 652 ASN GLY GLY GLY ALA PHE MET PHE PRO TYR PHE ILE MET SEQRES 8 A 652 LEU ILE PHE CYS GLY ILE PRO LEU PHE PHE MET GLU LEU SEQRES 9 A 652 SER PHE GLY GLN PHE ALA SER GLN GLY CYS LEU GLY VAL SEQRES 10 A 652 TRP ARG ILE SER PRO MET PHE LYS GLY VAL GLY TYR GLY SEQRES 11 A 652 MET MET VAL VAL SER THR TYR ILE GLY ILE TYR TYR ASN SEQRES 12 A 652 VAL VAL ILE CYS ILE ALA PHE TYR TYR PHE PHE SER SER SEQRES 13 A 652 MET THR HIS VAL LEU PRO TRP ALA TYR CYS ASN ASN PRO SEQRES 14 A 652 TRP ASN THR HIS ASP CYS ALA GLY VAL LEU ASP ALA SER SEQRES 15 A 652 ASN LEU THR ASN GLY SER ARG PRO ALA ALA LEU PRO SER SEQRES 16 A 652 ASN LEU SER HIS LEU LEU ASN HIS SER LEU GLN ARG THR SEQRES 17 A 652 SER PRO SER GLU GLU TYR TRP ARG LEU TYR VAL LEU LYS SEQRES 18 A 652 LEU SER ASP ASP ILE GLY ASN PHE GLY GLU VAL ARG LEU SEQRES 19 A 652 PRO LEU LEU GLY CYS LEU GLY VAL SER TRP LEU VAL VAL SEQRES 20 A 652 PHE LEU CYS LEU ILE ARG GLY VAL LYS SER SER GLY LYS SEQRES 21 A 652 VAL VAL TYR PHE THR ALA THR PHE PRO TYR VAL VAL LEU SEQRES 22 A 652 THR ILE LEU PHE VAL ARG GLY VAL THR LEU GLU GLY ALA SEQRES 23 A 652 PHE ASP GLY ILE MET TYR TYR LEU THR PRO GLN TRP ASP SEQRES 24 A 652 LYS ILE LEU GLU ALA LYS VAL TRP GLY ASP ALA ALA SER SEQRES 25 A 652 GLN ILE PHE TYR SER LEU GLY CYS ALA TRP GLY GLY LEU SEQRES 26 A 652 ILE THR MET ALA SER TYR ASN LYS PHE HIS ASN ASN CYS SEQRES 27 A 652 TYR ARG ASP SER VAL ILE ILE SER ILE THR ASN CYS ALA SEQRES 28 A 652 THR SER VAL TYR ALA GLY PHE VAL ILE PHE SER ILE LEU SEQRES 29 A 652 GLY PHE MET ALA ASN HIS LEU GLY VAL ASP VAL SER ARG SEQRES 30 A 652 VAL ALA ASP HIS GLY PRO GLY LEU ALA PHE VAL ALA TYR SEQRES 31 A 652 PRO GLU ALA LEU THR LEU LEU PRO ILE SER PRO LEU TRP SEQRES 32 A 652 SER LEU LEU PHE PHE PHE MET LEU ILE LEU LEU GLY LEU SEQRES 33 A 652 GLY THR GLN PHE CYS LEU LEU GLU THR LEU VAL THR ALA SEQRES 34 A 652 ILE VAL ASP GLU VAL GLY ASN GLU TRP ILE LEU GLN LYS SEQRES 35 A 652 LYS THR TYR VAL THR LEU GLY VAL ALA VAL ALA GLY PHE SEQRES 36 A 652 LEU LEU GLY ILE PRO LEU THR SER GLN ALA GLY ILE TYR SEQRES 37 A 652 TRP LEU LEU LEU MET ASP ASN TYR ALA ALA SER PHE SER SEQRES 38 A 652 LEU VAL VAL ILE SER CYS ILE MET CYS VAL ALA ILE MET SEQRES 39 A 652 TYR ILE TYR GLY HIS ARG ASN TYR PHE GLN ASP ILE GLN SEQRES 40 A 652 MET MET LEU GLY PHE PRO PRO PRO LEU PHE PHE GLN ILE SEQRES 41 A 652 CYS TRP ARG PHE VAL SER PRO ALA ILE ILE PHE PHE ILE SEQRES 42 A 652 LEU VAL PHE THR VAL ILE GLN TYR GLN PRO ILE THR TYR SEQRES 43 A 652 ASN HIS TYR GLN TYR PRO GLY TRP ALA VAL ALA ILE GLY SEQRES 44 A 652 PHE LEU MET ALA LEU SER SER VAL LEU CYS ILE PRO LEU SEQRES 45 A 652 TYR ALA MET PHE ARG LEU CYS ARG THR ASP GLY ASP THR SEQRES 46 A 652 LEU LEU GLN ARG LEU LYS ASN ALA THR LYS PRO SER ARG SEQRES 47 A 652 ASP TRP GLY PRO ALA LEU LEU GLU HIS ARG THR GLY ARG SEQRES 48 A 652 TYR ALA PRO THR ILE ALA PRO SER PRO GLU ASP GLY PHE SEQRES 49 A 652 GLU VAL GLN PRO LEU HIS PRO ASP LYS ALA GLN ILE PRO SEQRES 50 A 652 ILE VAL GLY SER ASN GLY SER SER ARG LEU GLN ASP SER SEQRES 51 A 652 ARG ILE HET W5F A 701 29 HETNAM W5F ALX5407 HETSYN W5F 2-[[(3~{R})-3-(4-FLUOROPHENYL)-3-(4-PHENYLPHENOXY) HETSYN 2 W5F PROPYL]-METHYL-AMINO]ETHANOIC ACID; ALX-5407; (R)-NFPS FORMUL 2 W5F C24 H24 F N O3 HELIX 1 AA1 GLU A 54 VAL A 64 1 11 HELIX 2 AA2 GLY A 65 TRP A 70 1 6 HELIX 3 AA3 TRP A 70 GLY A 80 1 11 HELIX 4 AA4 GLY A 81 CYS A 95 1 15 HELIX 5 AA5 GLY A 96 ALA A 110 1 15 HELIX 6 AA6 SER A 121 MET A 123 5 3 HELIX 7 AA7 PHE A 124 TYR A 141 1 18 HELIX 8 AA8 TYR A 141 SER A 155 1 15 HELIX 9 AA9 SER A 209 TYR A 218 1 10 HELIX 10 AB1 ARG A 233 ARG A 253 1 21 HELIX 11 AB2 THR A 267 ARG A 279 1 13 HELIX 12 AB3 PHE A 287 THR A 295 1 9 HELIX 13 AB4 GLU A 303 SER A 317 1 15 HELIX 14 AB5 GLY A 323 TYR A 331 1 9 HELIX 15 AB6 ASN A 337 GLY A 372 1 36 HELIX 16 AB7 ASP A 374 VAL A 378 5 5 HELIX 17 AB8 ALA A 389 LEU A 397 1 9 HELIX 18 AB9 ILE A 399 GLU A 433 1 35 HELIX 19 AC1 LYS A 442 GLY A 458 1 17 HELIX 20 AC2 ILE A 459 SER A 463 5 5 HELIX 21 AC3 ALA A 465 TYR A 495 1 31 HELIX 22 AC4 GLY A 498 LEU A 510 1 13 HELIX 23 AC5 PRO A 515 PHE A 524 1 10 HELIX 24 AC6 PHE A 524 THR A 537 1 14 HELIX 25 AC7 PRO A 543 ASN A 547 5 5 HELIX 26 AC8 PRO A 552 SER A 566 1 15 HELIX 27 AC9 LEU A 568 THR A 581 1 14 HELIX 28 AD1 LEU A 587 LYS A 595 1 9 SSBOND 1 CYS A 166 CYS A 175 1555 1555 2.27 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 CONECT 907 983 CONECT 983 907 CONECT 4121 4122 4123 CONECT 4122 4121 4124 4147 CONECT 4123 4121 4146 CONECT 4124 4122 4127 4128 CONECT 4125 4136 4146 CONECT 4126 4146 CONECT 4127 4124 4130 CONECT 4128 4124 4131 CONECT 4129 4132 4133 4147 CONECT 4130 4127 4135 CONECT 4131 4128 4135 CONECT 4132 4129 4137 CONECT 4133 4129 4138 CONECT 4134 4137 4138 4139 CONECT 4135 4130 4131 4145 CONECT 4136 4125 4148 4149 CONECT 4137 4132 4134 CONECT 4138 4133 4134 CONECT 4139 4134 4140 4141 CONECT 4140 4139 4142 CONECT 4141 4139 4143 CONECT 4142 4140 4144 CONECT 4143 4141 4144 CONECT 4144 4142 4143 CONECT 4145 4135 CONECT 4146 4123 4125 4126 CONECT 4147 4122 4129 CONECT 4148 4136 CONECT 4149 4136 MASTER 279 0 1 28 0 0 0 6 4148 1 31 51 END